These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 5431856)

  • 1. Newcastle disease in turkeys. Determination of the 50 per cent. Lethal dose of the Herts (1933) Weybridge strain of Newcastle disease virus and the potency of B.P.L. inactivated Newcastle disease vaccine in turkeys.
    Box PG; Helliwell BI; Halliwell PH
    Vet Rec; 1970 May; 86(18):524-7. PubMed ID: 5431856
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose-response effects of inactivated Newcastle disease vaccines: influence of serologic assay, time after vaccination, and type of chickens.
    Maas RA; Oei HL; Venema-Kemper S; Koch G; Bongers J
    Avian Dis; 1999; 43(4):670-7. PubMed ID: 10611983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of chickens against challenge with the variant virus responsible for Newcastle disease in 1984 by conventional vaccination.
    Alexander DJ; Parsons G
    Vet Rec; 1986 Feb; 118(7):176-7. PubMed ID: 3962129
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on the use of Komarov strain of Newcastle disease vaccine in the Sudan.
    Gaffar Elamin MA; Khalafalla AI; Ahmed SM
    Trop Anim Health Prod; 1993 Aug; 25(3):151-4. PubMed ID: 8236491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. La Sota vaccination may not protect against virus shedding and the lesions of velogenic Newcastle disease in commercial turkeys.
    Okoroafor O; Eze PC; Ezema WS; Nwosu C; Okorie-Kanu C; Animoke PC; Anene B; Okoye JOA
    Trop Anim Health Prod; 2018 Feb; 50(2):345-351. PubMed ID: 28980209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of viable and inactivated Newcastle disease virus vaccines in turkeys.
    Kelleher CJ; Halvorson DA; Newman JA
    Avian Dis; 1988; 32(2):342-6. PubMed ID: 3401177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to Newcastle disease.
    Beard CW; Brugh M
    Am J Vet Res; 1975 Apr; 36(4 Pt 2):509-12. PubMed ID: 1092218
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antigenicity and immunization studies on the B1 vaccine strain used against Newcastle disease in the fowl, turkey and psittacines].
    Bengelsdorf HJ
    Zentralbl Veterinarmed B; 1974; 21(1):22-31. PubMed ID: 4856815
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of minimum hemagglutinin units in an inactivated Newcastle disease virus vaccine for clinical protection of chickens from exotic Newcastle disease virus challenge.
    Liljebjelke KA; King DJ; Kapczynski DR
    Avian Dis; 2008 Jun; 52(2):260-8. PubMed ID: 18646455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newcastle disease vaccination in Malaysia: application of oil emulsion vaccine.
    Ernawati R; Ibrahim AL
    Vet Rec; 1984 Oct; 115(14):352-4. PubMed ID: 6495601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens.
    Heckert RA; Riva J; Cook S; McMillen J; Schwartz RD
    Avian Dis; 1996; 40(4):770-7. PubMed ID: 8980804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virulence and transmissibility of some Australian and exotic strains of Newcastle disease virus used in some vaccines.
    Hansson E; Young JG; Hooper PT; Della-Porta AJ
    Aust Vet J; 1999 Jan; 77(1):51-3. PubMed ID: 10028398
    [No Abstract]   [Full Text] [Related]  

  • 15. Field vaccination of turkeys against exotic viscerotropic Newcastle disease virus.
    Stone HD; Boney WA
    Avian Dis; 1973; 17(1):159-65. PubMed ID: 4697708
    [No Abstract]   [Full Text] [Related]  

  • 16. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
    Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination against Newcastle disease with an inactivated oil emulsion vaccine at day-old followed by aerosol application of La Sota vaccine at three weeks.
    Allan WH
    Vet Rec; 1974 Jan; 94(3):54. PubMed ID: 4816762
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccination against Newcastle disease: An assessment of haemagglutination inhibition titres obtained from field samples.
    Phillips JM
    Vet Rec; 1973 Dec; 93(22):577-83. PubMed ID: 4785347
    [No Abstract]   [Full Text] [Related]  

  • 19. Viscerotropic velogenic Newcastle disease in turkeys: immune response following vaccination with either viable B1 strain or inactivated vaccine.
    Boney WA; Stone HD; Gillette KG; Coria MF
    Avian Dis; 1975; 19(1):19-30. PubMed ID: 1120031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Chicken Interferon Gamma on Newcastle Disease Virus Vaccine Immunogenicity.
    Cardenas-Garcia S; Dunwoody RP; Marcano V; Diel DG; Williams RJ; Gogal RM; Brown CC; Miller PJ; Afonso CL
    PLoS One; 2016; 11(7):e0159153. PubMed ID: 27409587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.